Immune low-response states significantly impact the effectiveness of immunotherapy in cancer treatment. These states ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression sustained improvement in kidney ...

Scientists at the Wellcome Sanger Institute and EMBL’s European Bioinformatics Institute (EMBL-EBI) in Hinxton mapped the ...

Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

A research group has developed a novel and highly accessible technology for producing uniform biomolecular condensates using ...

Festive favorites of the holiday season, reindeer possess remarkable genomic adaptations that allow them to thrive in the ...

Disrupted circadian rhythms from night shifts, irregular sleep schedules or frequently flying across time zones can fuel ...

A new imaging technology can distinguish cancerous tissue from healthy cells by detecting ultra-weak light signals. It relies ...

The most comprehensive dataset of termite genomes to date was created by an international team of scientists, led by ...